Nemonoxacin dosage adjustment in patients with severe renal impairment based on population pharmacokinetic and pharmacodynamic analysis-Reference-Cited by-同舟云学术

Nemonoxacin dosage adjustment in patients with severe renal impairment based on population pharmacokinetic and pharmacodynamic analysis

Published:2021-05-18 Issue:12 Volume:87 Page:4636-4647
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Li Yi¹²³,Lu Jianda⁴,Kang Yue¹²³,Xu Xiaoyong⁵,Li Xin¹²³,Chen Yuancheng²³⁶,Wang Kun⁷,Liu Xiaofen¹²³,Fan Yaxin¹²³,Wu Hailan¹²³,Wang Yu¹²³,Hu Jiali¹²³,Yu Jicheng²³⁶,Wu Jufang²³⁶,Guo Beining¹²³,Zhang Yingyuan¹²³,Zeng Xin¹²³⁸,Zhao Ming⁸,Xue Jun⁴,Zhang Jing¹²³⁶^ORCID

Affiliation:

1. Institute of Antibiotics, Huashan Hospital Fudan University Shanghai China

2. China Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health Shanghai China

3. National Clinical Research Center for Geriatric Diseases, Huashan Hospital Fudan University Shanghai China

4. Department of Nephrology, Huashan Hospital Fudan University Shanghai China

5. Shanghai Medical College Fudan University Shanghai China

6. Phase I Unit, Huashan Hospital Fudan University Shanghai China

7. Shanghai Qiangshi Information Technology Co., Ltd Shanghai China

8. Center for Drug Evaluation, National Medical Products Administration Beijing China

Funder

Ministry of Science and Technology of the People's Republic of China

Shanghai Municipal Education Commission